Evidence map›Paper›PMID 40643044›Full record

SynthesisHuman vaccines & immunotherapeutics2025

Characterizing adolescent vaccination in publicly funded national immunization programs in Latin America and the Caribbean: A review of the literature.

Monica Rojas, Maria Florencia Lución, Ricardo Becker Feijó, Antonio Luevanos, Ivan Felipe Gutierrez Tobar, Dora Estripeaut, Andrea Schilling, Jessica Webster, Maria Eugenia Perez, Luciana Hirata and 2 more

Abstract readSystematic Review
In one paragraph

Synthesis in Human vaccines & immunotherapeutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Monica RojasOutcomes Research-Regional Latin America, MSD Colombia SAS, Bogotá, Colombia.
Maria Florencia LuciónDepartment of Epidemiology, Hospital de Niños Dr. Ricardo Gutiérrez, Buenos Aires, Argentina.
Ricardo Becker FeijóDepartment of Pediatrics Hospital de Clínicas de Porto Alegre, Federal University of Rio Grande do Sul (UFRGS), Porto Alegre, Brazil.
Antonio LuevanosDepartment of Pediatrics and Infectious Diseases, Antiguo Hospital Civil de Guadalajara, Guadalajara, Mexico.
Ivan Felipe Gutierrez TobarDepartment of Pediatrics and Infectious Diseases, Clínica Infantil Santa María del Lago and Clínica Infantil Colsubsidio, Bogotá, Colombia.
Dora EstripeautDepartment of Pediatric Infectious Diseases, Hospital del Niño Doctor José Renán Esquivel, Panamá City, Panama.
Andrea SchillingInstitute of Science and Innovation in Medicine (ICIM), Facultad de Medicina Clínica Alemana Universidad del Desarrollo, Santiago, Chile.
Jessica WebsterOutcomes Research, Merck & Co., Inc., Rahway, NJ, USA.
Maria Eugenia PerezGlobal Medical and Scientific Affairs, Merck Sharp & Dohme Argentina Inc., Buenos Aires, Argentina.
Luciana HirataOutcomes Research - Regional Latin America, MSD Brazil, São Paulo, Brazil.
Juan Carlos OrengoOutcomes Research - Regional Latin America, MSD Puerto Rico, Barceloneta, Puerto Rico.
Cintia Irene ParelladaOutcomes Research - Regional Latin America, MSD Brazil, São Paulo, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This review aimed to characterize adolescent vaccination schedules in publicly funded national immunization programs in Latin America and the Caribbean. The initial review identified vaccine type, target age and gender, dose schedule, and vaccination coverage rate (VCR) across 50 countries/territories in the region. A systematic review from January 2010-October 2023 was then conducted to identify primary data collection studies reporting VCRs. Overall, 42 webpages and 23 primary studies were identified. Among 47 countries/territories with ≥1 vaccine for adolescent immunization, human papillomavirus (HPV) vaccine was included in 45, tetanus component vaccines in 43, and meningococcal vaccines in 10. Catch-up vaccination for hepatitis B in 17, and yellow fever in all 13 endemic countries/territories. VCRs were primarily available for HPV. The findings of this review underscore the need to prioritize adolescent vaccination, improve accessibility, and strengthen tracking infrastructure to ensure comprehensive protection of this age group across the region.

Indexed as

Immunization ProgramsVaccinationVaccination CoverageAdolescentCaribbean RegionFemaleHumansImmunization ScheduleLatin AmericaMaleMeningococcal VaccinesPapillomavirus VaccinesMeningococcal VaccinesPapillomavirus VaccinesAdolescentimmunizationLatin America and Caribbeanvaccination coveragevaccinesvaccine uptake

Identifiers

PMID40643044
PMCPMC12258168

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.